CIK 0001444192 · Non-accelerated filer<br>Smaller reporting company
Grace Therapeutics, Inc.
Sign in to watch- Ticker
- GRCE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 609-322-1602
- Business address
- 103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
- Former names
- Acasti Pharma Inc.
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Regulation FD disclosure
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
Page 15 of 30 · 596 filings